Recombinant Anti-IL17 x Anti-IL23 Bispecific Antibody (IgG-Fv) (BSGV-174)

Recombinant Anti-IL17 x Anti-IL23 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-IL17 antibody variable domain is fused to the C terminal of an IgG of anti-IL23 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Autoimmune diseases; Cancers therapy.

Datasheet INQUIRY

Specifications

Targets

IL17 & IL23

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Autoimmune diseases; Cancers

Targets

Target 1

IL17

Gene ID

3605

UniProt ID

Q16552

Alternative Names

IL17A; interleukin 17A; IL17; CTLA8; IL-17; IL-17A; interleukin-17A; CTLA-8; cytotoxic T-lymphocyte-associated antigen 8; cytotoxic T-lymphocyte-associated protein 8; interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8)

Target 2

IL23

Gene ID

51561

UniProt ID

Q9NPF7

Alternative Names

P19; SGRF; IL-23; IL-23A; IL23P19; Interleukin-23; IL23; interleukin 23 subunit alpha

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-IL17 x Anti-IL23 Bispecific Antibody (IgG-Fv) (BSGV-174). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-IL17 x Anti-IL23 Bispecific Antibody (IgG-Fv) (CAT#: BSGV-174)

Specifications

Targets

Customer Reviews and Q&As